Genetron Health’s Co-Founder and Chief Scientific Officer Awarded International Prize for Translational Neuroscience 2021
August 30, 2021 06:00 ET
|
Genetron Holdings Limited
BEIJING, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reports Second Quarter 2021 Unaudited Financial Results
August 24, 2021 07:23 ET
|
Genetron Holdings Limited
BEIJING, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference
August 23, 2021 17:00 ET
|
Genetron Holdings Limited
BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reaches Strategic Partnership with Yikon Genomics, Expanding S5 Platform’s Reach to Reproductive Health Field
August 23, 2021 07:00 ET
|
Genetron Holdings Limited
BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Announce Second Quarter 2021 Financial Results and Host Investor Call on August 24, 2021
August 11, 2021 08:00 ET
|
Genetron Holdings Limited
BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Tops NCCL’s External Quality Assessment of NGS-based Comprehensive Genomic Profiling for Solid Tumors with Full Marks
August 11, 2021 07:21 ET
|
Genetron Holdings Limited
BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Partners with Guizhou Province’s Dafang County to Lead Liver Cancer Early Screening Project
July 29, 2021 04:35 ET
|
Genetron Holdings Limited
BEIJING, July 29, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in China
July 26, 2021 06:00 ET
|
Genetron Holdings Limited
BEIJING, July 26, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx)...
Genetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA Reference Panel Comparative Data of its SARS-CoV-2 RNA Test
July 13, 2021 08:30 ET
|
Genetron Holdings Limited
BEIJING, July 13, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Enters into Platform Partnership with World Economic Forum
July 01, 2021 22:00 ET
|
Genetron Holdings Limited
BEIJING, July 02, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...